These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 767112)

  • 41. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 43. Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
    Mathé G; Pouillart P; Lapeyraque F
    Br J Cancer; 1969 Dec; 23(4):814-24. PubMed ID: 4312660
    [No Abstract]   [Full Text] [Related]  

  • 44. Correlations between humoral immunity and successful chemotherapy-immunotherapy.
    Cantrell JL; Killion JJ; Kollmorgen GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3051-7. PubMed ID: 788896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice.
    Meltzer MS
    Cell Immunol; 1976 Mar; 22(1):176-81. PubMed ID: 776413
    [No Abstract]   [Full Text] [Related]  

  • 46. Introduction: animal models of immunotherapy of cancer.
    Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():1-2. PubMed ID: 4595318
    [No Abstract]   [Full Text] [Related]  

  • 47. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 48. Introduction of "natural" killer' cells by BCG.
    Wolfe SA; Tracey DE; Henney CS
    Nature; 1976 Aug; 262(5569):584-6. PubMed ID: 785281
    [No Abstract]   [Full Text] [Related]  

  • 49. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukemia and Lewis Tumor.
    Mathé G; Halle-Pannenko O; Bourut C
    Recent Results Cancer Res; 1977; (62):62-6. PubMed ID: 601338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 53. HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy.
    Klouda TP; Lawler SD; Powles RL; Oliver RT; Grant CK
    Transplantation; 1975 Mar; 19(3):245-9. PubMed ID: 1094639
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunochemotherapy of human cancer.
    Gutterman JU; Mavligit GM; Reed RC; Hersh EM
    Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
    [No Abstract]   [Full Text] [Related]  

  • 55. [BCG vaccine in cancer immunotherapy].
    Azuma I; Saiki I
    Rinsho Ketsueki; 1980 Sep; 21(9):1333-5. PubMed ID: 7452921
    [No Abstract]   [Full Text] [Related]  

  • 56. Interaction of macrophages with tumor cells.
    Stewart CC; Adles C; Hibbs JB
    Adv Exp Med Biol; 1976; 73 Pt B():423-33. PubMed ID: 793342
    [No Abstract]   [Full Text] [Related]  

  • 57. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
    Smith HG; Bast RC; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of pretreatment with BCG on infection with Schistosoma mansoni in mice and monkeys.
    Maddison SE; Chandler FW; Kagan IG
    J Reticuloendothel Soc; 1978 Dec; 24(6):615-28. PubMed ID: 109612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.